Samsung NeuroLogica and MedyMatch Partner to Launch AI-Enhanced Mobile CT Platform for Emergency Stroke Care

In the United States, there is a type of ambulance known as a "Mobile Stroke Unit," which is specifically designed for stroke cases.Samsung's Medical Imaging CompanyNeuroLogica has partnered with the Israeli artificial intelligence company MedyMatch to develop an AI platform integrated with Samsung’s CereTom CT scanner for this type of ambulance unit. This integration enables emergency physicians to rapidly determine whether a patient is suffering from a cerebral hemorrhage or a thrombus when using this mobile scanning tool. VCBeat (WeChat ID: vcbeat) compiled the relevant information.

MedyMatch’s AI-powered diagnostic capabilities will be integrated with Samsung’s CereTom (Image source:PR Newswire）

At SamsungAt the joint press conference held by NeuroLogica and MedyMatch, Dr. Peter Rasmussen, Medical Director of the Cleveland Clinic’s Telemedicine Program, stated that a scanning device capable of rapidly differentiating cerebral hemorrhage is critically important, as treatment decisions in such scenarios must be made with utmost urgency.

Early March 2017,MedyMatch has partnered with IBM Watson Health to bring its intracerebral hemorrhage diagnosis application to a broader market. The two companies are integrating this application with IBM Watson’s imaging business.

AndThe integration of MedyMatch with Samsung’s NeroLogica is merely the beginning of the “Roadside AI” project, which aims to apply a fusion of machine learning and mobile health technology to all emergency medical scenarios.

“We are standing at a new threshold in medical imaging,” said the CEO of MedyMatch at the press conference. He stated that the evolution of medical imaging has always focused on clearer imaging and more portable devices, and MedyMatch’s AI applications will help advance this trend, enabling imaging modalities such as CT scanners to provide not only images but also medical insights.

Numerous studies have demonstrated that providing treatment within the first few hours after the onset of stroke symptoms can effectively save lives and mitigate the impact of the condition. Consequently, many healthcare providers are currently“Mobile Stroke Care Unit” trials, as it relocates fixed-point medical services from hospitals to the patient’s location.

In 2015,Cleveland Clinic、Cleveland Emergency Medical ServicesA study was conducted and found that services such as mobile stroke care units can at least enable patients to receive earlierCT scan completed in 5 minutes; thrombolytic therapy administered 26 minutes earlier.

Chicago is one of the first cities to begin testing mobile stroke units, with Northwestern Medicine Delnor Hospital and Rush University Medical Center in Chicago both deploying specially equipped ambulances for emergency care.

Northwestern Medicine Central DuPage HospitalStroke and Blood VesselsMedical DirectorHarish Shownkeen believes that this specialized ambulance device is a brilliant technology that will soon become standard. “Treatment itself has never changed; what has changed is the level of sophistication in treatment tools.”

James Conners, Director of Cerebrovascular Diseases at Rush University Medical Center, further emphasized that time is truly critical for stroke patients, as approximately 2 million brain cells die every minute during a cerebral infarction.

SamsungPhillip Sullivan, CEO of NeuroLogica, stated that in addition to Chicago, “mobile CT scanning units” from Samsung NeuroLogica are deployed in New York; Trenton, New Jersey; Alberta, Canada; and even in Thailand, India, and Germany. “Our partnership with the Israeli artificial intelligence company MedyMatch represents a further advancement in stroke-support technology.”

Source: mhealthintelligence.com